Title: Evaluation of Total protein, Albumin, Aspartate Transaminase (SGOT), Urea and Creatinine in Third Trimester of Preeclampsia and Their Effect on Obstetric Outcome: A prospective study

Authors: Dr Anjan Dasgupta, Dr Bikash Ranjan Singh, MS (G&O), Mrs Sanghamitra Dasgupta

 DOI: https://dx.doi.org/10.18535/jmscr/v7i5.73

Abstract

Preeclampsia, a clinical condition manifested by new onset hypertension (=/> 140/90 mm of Hg) after 20 weeks of gestation with proteinuria with or without evidence of multiorgan involvement. Generalized vasoconstriction that occurs in severe preeclampsia and subsequent multiorgan dysfunction secondary to reduced perfusion, hypoxia, activation of coagulation cascade and loss of endothelial integrity causes characteristic clinical features like hypertension, proteinuria, hypoproteinemia, hemolysis, raised liver enzymes, low platelet count and raised level of urea, creatinine and uric acid. Abnormal values of these parameters are considered as markers of severe preeclampsia which badly affect the course of pregnancy and obstetric outcome though no single marker has been established to have high predictive value.

Materials and Method: This prospective study was carried out for one and half years during the year 2015-16 at a peripheral Medical College of West Bengal, India with Ethical approval. The study population included the antenatal mothers who attended antenatal OPD from the first trimester of pregnancy. The aim of the study was to evaluate the biochemical changes, mainly of liver and kidneys associated with preeclampsia and how it affected the outcome of pregnancy. A total of 100 mothers were taken as case-control study. Group one (n=50) were the mothers having increase systolic pressure >30 mm Hg and diastolic blood pressure >15 mm Hg above their booking blood pressure for two consecutive clinic attendance and presence of  proteinuria by dipstick test, serve as case;  group two (n=50) were the mothers  with normal systolic and diastolic blood pressure throughout  the pregnancy ,serve as control; All biochemical and hematological investigations were done in central pathological lab of the Institution and ultrasonography at the Department of Radiology. All other data collected from Labour Room Record Book, Antenatal Record Book, Logbook, OT Registrar and Bed Head Ticket and data analyzed at the end of the study.

Results & Analysis: According to parity, 42 out of 50 mother in preeclampsia group were primigravida (p value 0.046) rectify nulliparity is a risk factor. There was significant proteinuria among preeclampsia mothers compared to normotensive mothers (P value< 0.05).The study showed preeclampsia group have statistically less Hb% (p value <0.05), less mean total protein (p value< 0.05), less mean albumin (p value< 0.05), abnormal rise of AST (aspartate aminotransferase) (p value< 0.05) and significant rise of blood urea (p value <0.05) at term in comparison to normotensive group. There was higher incidence of LUCS delivery (p value< 0.05) and preterm, IUGR and low birth weight (LBW) babies (p value< 0.05) among preeclampsia mothers than that of normotensive mothers. In evaluation of birth conditions per Apgar score index, relative risk of life expectancy was greater in preeclampsia group (P value< 0.05) than that of normotensive group. In this regard, SNCU admission in preeclampsia group was much higher than normotensive group (P value< 0.05). The duration of hospital stay was more in preeclampsia mother compared to normotensive mother (p value< 0.05) and significant number of mother admitted to ICU in preeclampsia group than that of normotensive group ( P value< 0.05).

Conclusion: In preeclampsia, involvements of multiorgan complicate the course of pregnancy more severely. In this connection, evaluation of different parameters like degree of proteinuria, gestational age, available Hb%, biomarkers like serum total protein, serum albumin, AST, serum urea and creatinine should be justified for the timing delivery in preeclampsia mother and thus a better obstetric outcome could be ascertained.

Keyword:  Preeclampsia, Normotensive, Proteinuria, Aspartate aminotransferase (AST), Low birth weight (LBW).

References

  1. Sibai BM: Diagnosis and management of gestational hypertension and preeclampsia, Obstet Gynecol 102: 181;2003.
  2. Geneva : WHO2005. World Health Organization. Make Every Mother and Child Count. World Health  Report 2005.         
  3. Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyer GJ. Preeclampsia.Lancet 2015 Sep2;pii:So140-6736(15)00070-7.
  4. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Preeclampsia Part-1: Current Understanding of its Pathophysiology. Nat Rev Nephrol. 2014 Aug:10(8):466-80. doi:10.1038/nrneph.2014.102[PMC free article] [Pub Med].
  5. Madazli R, Budak E, Calay Z,et al: Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in preeclampsia. Br J Obstet Gynecol 107;514,2000.
  6. Ajne G, Wolff K, Fyhrquist F, et al: Endothelin converting enzyme (ECE) activity in normal pregnancy and preeclampsia. Hypertens Pregnancy 22:215,2003.
  7. Taylor RN, Roberts JM: Endothelial cell dysfunction. In Lindheimer MD, Roberts JM, Cunningham FG(eds): Chesley’s Hypertensive Disorder in Pregnancy, 2nd Stamford, CT, Appleton& Lange, 1999,p395.
  8. Masse, JY Giguere, A. Kharfi, J. Girouard and J.C. Forest, 2002. Pathophysiology and maternal biologic markers of preeclampsia. Endocrine,19: 123-125.
  9. William Obstetrics,24th Edition, McGraw-Hill Education: Hypertensive Disorder of Pregnancy: Chapter40;p 740-41;2014.
  10. Latifah A. Rahman, Norman N. Hairi, Nooriah Salleh. Association between pregnancy induced hypertension and Low Birth Weight; A Population Based Case Control Study. Asia Pac J Public Health.2008;20(2):152-8.doi:10.1177/1010.
  11. Sibai BM; Preeclampsia as a cause of preterm and late preterm (near term) births. Semin Perinatol. 2006 Feb; 30(1): 16-9.
  12. Bhatia RK, SF Bottoms, AA Saleh, GS Norman, EF Mammen and RJ Sokol,1987: Mechanisms for reduced for reduced colloid osmotic pressure in preeclampsia. Am J Odstet Gynecol; 157: 106-108.
  13. W E Olooto, AA Amballi, A O Mousuro,A A Adeleye T A Banjo: Assessment of total protein,albumin, Creatinine and aspartate Transaminase level in toxemia of pregnancy. J Med Sci,13(8): 791-796;2013.
  14. Benoit J, E Rey 2011. Preeclampsia: Should plasma albumin level be a criterion for severity: J Obstet Gynaecol. Can, 33: 922-926.
  15. Mohamed Abdulfatah Abdulmunem: The values of plasma uric acid, urea, Creatinine and electrolytes in diagnosis of preeclampsia: Thesis. Sudan University of Science and Technology, Science, 2005 -56p:ill; 28cm-Ms.c.
  16. Salako BL, Odukogbe AT, Olayemi O, Adedapo KS, Aimakhu CO, Alu FE, Ola B: Serum albumin, Creatinine, uric acid and hypertensive disorder of pregnancy. East Afr Med J. 2003,80: 424-428.
  17. Von Dadelszen P, L.A. Magee, R.M. Devarakonda, T. Hamilton and L.M. Ainsworth et al,2004. The prediction of adverse maternal outcomes in preeclampsia. J. Obstet. Gynaecol. Can,, 26: 871-879.

Corresponding Author

Dr Bikash Ranjan Singh, MS (G&O)

Senior Resident, Dept. of G&O. Midnapore Medical College, West Bengal, India